作者
Bruce K Tan, Aiko I Klingler, Julie A Poposki, Whitney W Stevens, Anju T Peters, Lydia A Suh, James Norton, Roderick G Carter, Kathryn E Hulse, Kathleen E Harris, Leslie C Grammer, Robert P Schleimer, Kevin C Welch, Stephanie S Smith, David B Conley, Robert C Kern, Atsushi Kato
发表日期
2017/2/1
期刊
Journal of Allergy and Clinical Immunology
卷号
139
期号
2
页码范围
699-703. e7
出版商
Elsevier
简介
REFERENCES 1. Baena-Cagnani CE, Teijeiro A, Canonica GW. Four-year follow-up in children with moderate/severe uncontrolled asthma after withdrawal of a 1-year omalizumab treatment. Curr Opin Allergy Clin Immunol 2015; 15: 267-71. 2. Arnaboldi PM, Behr MJ, Metzger DW. Mucosal B cell deficiency in IgA2/2 mice abrogates the development of allergic lung inflammation. J Immunol 2005; 175: 1276-85.
3. van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A, Janssen Bonas M, Dijksman TR, Labuda LA, et al. CD24 (hi) CD27 (1) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy 2014; 44: 517-28.
学术搜索中的文章
BK Tan, AI Klingler, JA Poposki, WW Stevens… - Journal of Allergy and Clinical Immunology, 2017